David A Ramsay insider trades

Open-market stock purchases and sales by David A Ramsay, Interim CFO at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2011.

Track record: 100% of 52 scored buys are up 5% or more since purchase, averaging +208%.

Recent trades

DateStockTradeValue
Apr 1, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Dec 19, 2025SVRA Savara IncSold$121K
Dec 9, 2025SVRA Savara IncBought (not open market)—

Companies traded

  • HALO Halozyme Therapeutics, Inc: 1 buy, last Apr 1, 2026
  • SVRA Savara Inc: 68 buys, 1 sale, last Dec 19, 2025
  • LJPC LA Jolla Pharmaceutical Co: 28 buys, last Aug 22, 2022
  • MSTX Mast Therapeutics, Inc: other filings, last Jan 20, 2017
  • ANX Adventrx Pharmaceuticals Inc: 3 buys, last Jul 28, 2012

Get free alerts when David A Ramsay files a new trade →